| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Larry J Suva | Q56473836 |
| P2093 | author name string | Robert J Griffin | |
| Issam Makhoul | |||
| P2860 | cites work | Circulating colony stimulating factor-1 and breast cancer risk | Q24648147 |
| Inflammation and cancer | Q24649640 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 | ||
| Beyond tumorigenesis: cancer stem cells in metastasis | Q28279788 | ||
| Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial | Q28288726 | ||
| Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue | Q28572355 | ||
| A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression | Q28645691 | ||
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
| A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
| Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
| The distribution of secondary growths in cancer of the breast. 1889 | Q29614314 | ||
| Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer | Q29615523 | ||
| Oncogenic pathway signatures in human cancers as a guide to targeted therapies | Q29615526 | ||
| Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways | Q29615855 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Cancer metastasis: building a framework | Q29616783 | ||
| Breast cancer metastasis: markers and models | Q29618061 | ||
| Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway | Q33228319 | ||
| Genes associated with breast cancer metastatic to bone | Q33240970 | ||
| Genomics and proteomics of bone cancer. | Q33261445 | ||
| Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis | Q33903716 | ||
| Clinical course and prognostic factors following bone recurrence from breast cancer | Q34065927 | ||
| The pathogenesis of cancer metastasis | Q34274658 | ||
| Clinical features of metastatic bone disease and risk of skeletal morbidity | Q34576366 | ||
| A cytokine-mediated link between innate immunity, inflammation, and cancer | Q34625152 | ||
| Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer | Q34813227 | ||
| Breast cancer metastasis to bone: it is not all about PTHrP. | Q35576773 | ||
| Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases | Q62392239 | ||
| Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development | Q70953052 | ||
| Road map to metastasis | Q73741331 | ||
| Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients | Q77425692 | ||
| Sorting out breast-cancer gene signatures | Q79579043 | ||
| Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer | Q79761781 | ||
| The management of asymptomatic skeletal breast cancer: a paradigm shift | Q80463854 | ||
| Validation of 70-gene prognosis signature in node-negative breast cancer | Q82083040 | ||
| [Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases] | Q83044950 | ||
| Ductal carcinoma in situ, complexities and challenges. | Q35806175 | ||
| Platelet glycoprotein Ib alpha supports experimental lung metastasis | Q35829198 | ||
| Microenvironmental and cellular consequences of altered blood flow in tumours | Q35904989 | ||
| The clinical course of bone metastases from breast cancer | Q36027636 | ||
| Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. | Q36442020 | ||
| BRCA1 regulates human mammary stem/progenitor cell fate | Q36446479 | ||
| Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer | Q36611104 | ||
| Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features. | Q36648280 | ||
| Risks and benefits of bisphosphonates | Q36696538 | ||
| Proteomic analysis of bone cancer: a review of current and future developments. | Q36841875 | ||
| Metastatic carcinoma of the long bones. | Q37021166 | ||
| The bone microenvironment in metastasis; what is special about bone? | Q37028803 | ||
| Clonal selection of metastasis within the life history of a tumor | Q37035831 | ||
| The importance of distant metastases in hormone-sensitive breast cancer | Q37086291 | ||
| Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future | Q37096879 | ||
| Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. | Q37177529 | ||
| Is tumor growth sustained by rare cancer stem cells or dominant clones? | Q37179962 | ||
| Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts | Q37247356 | ||
| Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. | Q37700375 | ||
| Percutaneous combined therapy for painful sternal metastases: a radiofrequency thermal ablation (RFTA) and cementoplasty protocol. | Q39324737 | ||
| Radiotherapy for palliation of symptoms in incurable cancer | Q39455812 | ||
| Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. | Q40052411 | ||
| Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption | Q40144580 | ||
| BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy | Q40345138 | ||
| Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. | Q40402253 | ||
| Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. | Q40858675 | ||
| CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract | Q41289962 | ||
| Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis | Q44049666 | ||
| Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group | Q44160812 | ||
| De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent | Q46068963 | ||
| Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy | Q46417627 | ||
| Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups | Q46576514 | ||
| Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial | Q46847543 | ||
| Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. | Q46952761 | ||
| Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone | Q47744334 | ||
| Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. | Q50709872 | ||
| Angiogenesis in the bone marrow of patients with breast cancer. | Q50759831 | ||
| Is cancer a disease of self-seeding? | Q57578467 | ||
| Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 | Q58466062 | ||
| Tumor growth need not be driven by rare cancer stem cells | Q59606871 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 703-713 | |
| P577 | publication date | 2009-05-14 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Mechanisms of bone metastases of breast cancer | |
| P478 | volume | 16 |
| Q39336799 | A case of skeletal and bone marrow metastases from breast cancer treated with eribulin mesylate. |
| Q33966547 | A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling. |
| Q40942283 | Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. |
| Q26796465 | Advances in cancer pain from bone metastasis |
| Q34025195 | Bone metastasis: mechanisms and therapeutic opportunities |
| Q57067872 | Calcium-sensing receptor in colorectal inflammation and cancer: Current insights and future perspectives |
| Q37668209 | Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans. |
| Q34023628 | Diagnosis and surgical management of breast cancer metastatic to the spine |
| Q35840465 | Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype |
| Q36206819 | Efficacy and Safety of Zoledronic Acid and Pamidronate Disodium in the Treatment of Malignant Skeletal Metastasis: A Meta-Analysis |
| Q34101059 | Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases |
| Q28651415 | Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database |
| Q30429199 | Fetuin-A (α2HS-Glycoprotein) Is a Major Serum Adhesive Protein That Mediates Growth Signaling in Breast Tumor Cells |
| Q36454749 | Fluorescence Lifetime Imaging of Apoptosis |
| Q39258976 | Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer. |
| Q28393898 | Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells |
| Q36837041 | Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis |
| Q47114983 | Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model |
| Q52670810 | Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data. |
| Q39511922 | Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice |
| Q38702293 | Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast |
| Q50240241 | MRI-compatible bone phantom for evaluating ultrasonic thermal exposures. |
| Q40390176 | MRI-guided focused ultrasound robotic system for the treatment of bone cancer |
| Q28084024 | Mechanisms involved in breast cancer liver metastasis |
| Q39093756 | Migration speed and directionality switch of normal epithelial cells after TGF-β1-induced EMT (tEMT) on micro-structured polydimethylsiloxane (PDMS) substrates with variations in stiffness and topographic patterning. |
| Q36476085 | Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction |
| Q91690264 | PMMA-Fe3O4 for internal mechanical support and magnetic thermal ablation of bone tumors |
| Q33619180 | Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK) |
| Q38212708 | Potential of targeted drug delivery system for the treatment of bone metastasis |
| Q89967663 | RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies |
| Q26860122 | Role of hypoxia-inducible factors in breast cancer metastasis |
| Q54643065 | Runx2 in human breast carcinoma: its potential roles in cancer progression |
| Q35004008 | Selumetinib produces a central core of apoptosis in breast cancer bone metastases in mice |
| Q37282121 | Serum sclerostin levels in renal cell carcinoma patients with bone metastases |
| Q88034348 | Surveillance nanotechnology for multi-organ cancer metastases |
| Q36581353 | Symptomatic cardiac metastases of breast cancer 27 years after mastectomy: a case report with literature review--pathophysiology of molecular mechanisms and metastatic pathways, clinical aspects, diagnostic procedures and treatment modalities |
| Q35932609 | Systems biology approach to studying proliferation-dependent prognostic subnetworks in breast cancer. |
| Q90339653 | The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis |
| Q27437809 | The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis |
| Q36107167 | Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. |
| Q35672049 | Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients |
| Q38721290 | Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis. |
| Q35140763 | Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis. |
| Q34022223 | Tumor-stromal interactions in bone metastasis |
| Q36430239 | Voltage-gated sodium channels and metastatic disease. |
| Q47792012 | Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model |
| Q53271314 | [The conceptual oligometastatic non-small cell lung cancer and therapeutic strategies]. |
| Q35185340 | microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis |
| Q35551725 | β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. |
Search more.